Knowledge Center
Patent / Jan 01, 1975
Doxycycline alkali metaphosphate complexes
Source:
GB 1463726
Treatment of doxycycline (I, .alpha.-6-desoxy-5-hydroxytetracycline) with HPO3 (mole ratio I-HPO3 = 1-5:1) in an inert medium (e.g., CHCl3 or MeOH), then treating the excess HPO3 with methanolic or ethanolic NaOH or KOH gave a doxycycline alkali polyphosphate complex x I.y MPO3.z HPO3 [M = Na or K, x = 1-5, y = 1-5, z = 1-5 (y+z = 6, x .ltoreq. z], the soly. of which is such that, when taken internally, it maintains a more even and higher oxycycline concn. in blood than the known doxycycline hyclate.
Also in the Knowledge Center
/ Apr 25, 2017
Scale-up of a DPI carrier-based formulation and blending process optimization
Read more
Scientific Article
/ Apr 25, 2017
Paddle Over Disk as a Dissolution Test for Orally Inhaled Fluticasone Propionate
Read more
Scientific Article
/ Apr 25, 2017
Optimization of Formulation and Process Parameters for the Manufacture of Inhalable Composite Particles by Spray-Drying
Read more
Scientific Article